Pages that link to "Q34315884"
Jump to navigation
Jump to search
The following pages link to Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum (Q34315884):
Displaying 50 items.
- In vitro activities of iboga alkaloid congeners coronaridine and 18-methoxycoronaridine against Leishmania amazonensis (Q24536041) (← links)
- Kappa opioids as potential treatments for stimulant dependence (Q24647849) (← links)
- Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years (Q26746137) (← links)
- Ibogaine-associated cardiac arrest and death: case report and review of the literature (Q26747731) (← links)
- Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment (Q28191634) (← links)
- Noribogaine, but not 18-MC, exhibits similar actions as ibogaine on GDNF expression and ethanol self-administration (Q28297349) (← links)
- Dopaminergic agents for the treatment of cocaine abuse (Q33666032) (← links)
- Mechanisms and genetic factors underlying co-use of nicotine and alcohol or other drugs of abuse (Q33859960) (← links)
- Mechanisms of action of ibogaine: relevance to putative therapeutic effects and development of a safer iboga alkaloid congener (Q33955956) (← links)
- Potential use of medicinal plants in the treatment of alcoholism (Q33994029) (← links)
- Iboga interactions with psychomotor stimulants: panacea in the paradox? (Q33998417) (← links)
- Novel pharmacotherapeutic treatments for cocaine addiction (Q34065088) (← links)
- Comparative neuropharmacology of ibogaine and its O-desmethyl metabolite, noribogaine (Q34101436) (← links)
- Fatalities temporally associated with the ingestion of ibogaine (Q34249047) (← links)
- Ibogaine: a review (Q34435889) (← links)
- Characterization of multiple sites of action of ibogaine (Q34435896) (← links)
- Sigma receptors and iboga alkaloids (Q34435917) (← links)
- Modulation of the effects of rewarding drugs by ibogaine (Q34435931) (← links)
- Drug discrimination studies with ibogaine (Q34435958) (← links)
- Clinical applications of hallucinogens: A review (Q34535259) (← links)
- Complementary alternative medicine and nuclear medicine. (Q35628631) (← links)
- Modulation of high alcohol drinking in the inbred Fawn-Hooded (FH/Wjd) rat strain: implications for treatment (Q36589468) (← links)
- Assessment of Neurotoxicity from Potential Medications for Drug Abuse: Ibogaine Testing and Brain Imaging (Q36873099) (← links)
- Ibogaine, an anti-addictive drug: pharmacology and time to go further in development. A narrative review (Q37225016) (← links)
- New therapeutic potential for psychoactive natural products (Q37660087) (← links)
- How toxic is ibogaine? (Q38710668) (← links)
- Effects of Ayahuasca and its Alkaloids on Drug Dependence: A Systematic Literature Review of Quantitative Studies in Animals and Humans. (Q38845469) (← links)
- Ibogaine and addiction in the animal model, a systematic review and meta-analysis. (Q38849032) (← links)
- The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging. (Q38861685) (← links)
- Antileishmanial activity of an indole alkaloid from Peschiera australis (Q39477065) (← links)
- Ibogaine and cocaine abuse: pharmacological interactions at dopamine and serotonin receptors (Q41313856) (← links)
- Pharmacological comparison of the effect of ibogaine and 18-methoxycoronaridine on isolated smooth muscle from the rat and guinea-pig (Q41785459) (← links)
- Effects of cyclazocine on cocaine self-administration in rats (Q42538794) (← links)
- Time-dependent interactions between iboga agents and cocaine (Q42546305) (← links)
- The acute effects of norharman on cocaine self-administration and sensorimotor function in male Wistar rats (Q43647939) (← links)
- Ibogaine and noribogaine potentiate the inhibition of adenylyl cyclase activity by opioid and 5-HT receptors (Q44344640) (← links)
- Evidence for roles of kappa-opioid and NMDA receptors in the mechanism of action of ibogaine (Q44345673) (← links)
- Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes (Q44345917) (← links)
- Individual differences in cocaine- and amphetamine-induced activation of male Sprague-Dawley rats: contribution of the dopamine transporter (Q45006429) (← links)
- Indole Alkaloids from Sickingia williamsii Reduce the In-vitro Effects of Morphine Withdrawal in the Guinea-pig (Q46595763) (← links)
- Ayahuasca: Psychological And Physiologic Effects, Pharmacology And Potential Uses In Addiction And Mental Illness. (Q47552333) (← links)
- Effect of ibogaine on the various sites of the NMDA receptor complex and sigma binding sites in rat brain (Q47823500) (← links)
- Ibogaine acts at the nicotinic acetylcholine receptor to inhibit catecholamine release (Q47962415) (← links)
- Acute iboga alkaloid effects on extracellular serotonin (5-HT) levels in nucleus accumbens and striatum in rats (Q48420572) (← links)
- Alteration of electroencephalogram and monoamine concentrations in rat brain following ibogaine treatment (Q48427798) (← links)
- Neurochemical and neuroendocrine effects of ibogaine in rats: comparison to MK-801. (Q48428328) (← links)
- Mechanisms of Antiaddictive Actions of Ibogainea (Q48482237) (← links)
- Ibogaine effects on sweet preference and amphetamine induced locomotion: implications for drug addiction (Q48527066) (← links)
- Sex Differences in Ibogaine Antagonism of Morphine-induced Locomotor Activity and in Ibogaine Brain Levels and Metabolism (Q48650618) (← links)
- Effects of chronic ibogaine treatment on cerebellar Purkinje cells in the rat (Q48683783) (← links)